Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathy D Miller

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Breast Cancer Research : BCR|April 16, 2004
Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?Kathy D Miller
Breast Cancer Research and Treatment|October 2, 2002
Issues and challenges for antiangiogenic therapiesKathy D Miller
Clinical Breast Cancer|March 15, 2003
E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancerKathy D Miller
The New England Journal of Medicine|June 6, 2017
Questioning Our APHINITY for MoreKathy D Miller
The Oncologist|May 28, 2004
The role of ErbB inhibitors in trastuzumab resistanceKathy D Miller
JAMA Oncology|September 25, 2025
Rethinking Ribociclib Dosage and Use in the Era of Patient-Centered Oncology-When Less Is MoreRina Yadav, Kathy D Miller
Cancer Treatment and Research|February 16, 2008
Development of new targeted therapies for breast cancerDanielle M Doyle, Kathy D Miller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2025
Carboplatin for Premenopausal Triple-Negative Breast Cancer: Time to Rethink the Neoadjuvant Standard?Rina K Yadav, Kathy D Miller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2022
Back to the Beginning: The Role of Ovarian Suppression in Management of Hormone Sensitive Breast Cancer in Premenopausal WomenRoisin M Connolly, Kathy D Miller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2005
Angiogenesis of breast cancerBryan P Schneider, Kathy D Miller
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Breast Cancer Research : BCR|April 16, 2004
Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?Kathy D Miller
Breast Cancer Research and Treatment|October 2, 2002
Issues and challenges for antiangiogenic therapiesKathy D Miller
Clinical Breast Cancer|March 15, 2003
E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancerKathy D Miller
The New England Journal of Medicine|June 6, 2017
Questioning Our APHINITY for MoreKathy D Miller
The Oncologist|May 28, 2004
The role of ErbB inhibitors in trastuzumab resistanceKathy D Miller
JAMA Oncology|September 25, 2025
Rethinking Ribociclib Dosage and Use in the Era of Patient-Centered Oncology-When Less Is MoreRina Yadav, Kathy D Miller
Cancer Treatment and Research|February 16, 2008
Development of new targeted therapies for breast cancerDanielle M Doyle, Kathy D Miller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2025
Carboplatin for Premenopausal Triple-Negative Breast Cancer: Time to Rethink the Neoadjuvant Standard?Rina K Yadav, Kathy D Miller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2022
Back to the Beginning: The Role of Ovarian Suppression in Management of Hormone Sensitive Breast Cancer in Premenopausal WomenRoisin M Connolly, Kathy D Miller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2005
Angiogenesis of breast cancerBryan P Schneider, Kathy D Miller
Pageof 21